Yale University School of Medicine, New Haven, Connecticut; the Center for Healthcare Policy and Research, University of California, Davis, Sacramento, California; the National Center for Health Research, Power to Decide, and Jhpiego, Reproductive Health and Family Planning, Washington, DC; and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Corresponding author: Aileen Gariepy, MD, Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT; email: [email protected].
Research reported in this article was funded through a Patient-Centered Outcomes Research Institute® (PCORI®) Award (1609–36359). The sponsor had no role in the study design; collection, analysis, and interpretation of data; manuscript writing; or decision to submit the report for publication. The statements presented in this article are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute® (PCORI®), its Board of Governors or Methodology Committee.
Financial Disclosure Aileen M. Gariepy disclosed that money was paid to her from UpToDate. Money was paid to her institution from the Society of Family Planning Research Fund. She is a member of the board of directors for the Society of Family Planning. Raegan McDonald-Mosley, Sarita Sonalkar, and Mark Hathaway received honorarium for participation in this study's advisory board—payment from PCORI (via Yale). Sarita Sonalkar was paid money from UpToDate and receives research funding from Evofem Pharmaceuticals. Mark Hathaway received payment from Afaxys as a member of their clinical advisory board. He received payment from Bayer and Med360 as a speaker and trainer for Mirena and Liletta IUDs. The other authors did not report any potential conflicts of interest.
Presented at the Society of Family Planning’s Annual Meeting, held virtually, October 9–10, 2020.
The authors thank Joyce Kilgore at the American College of Obstetricians and Gynecologists for her expertise in selecting claims codes and for the thoughtful contributions of our stakeholder advisory board: Nancy Abashian, Amy Barnett, Bridget Blayney, Claudia Castellanos, Misty Crompton, Jennifer Decker, Kimberly Hudak, Jennifer Jevne, Angela Lynch, Teressa Schulman, and Christy Seney, who all participated in planning and conducting the study, including interpretation of findings.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/C584.